Cardiovascular diseases are among the leading causes of maternal morbidity and mortality in the United States. During 2010–2020, 1 in 10 severe maternal morbidities (SMMs) during delivery hospitalization was heart disease (HD)-related. This report synthesizes science, including methodologies, challenges, and opportunities, and summarizes national estimates on HD during pregnancy, focusing on congenital heart disease (CHD), cardiomyopathies (CM), valvular heart disease (VHD), arrhythmias (ARR), and heart failure (HF).
Methods and Results:
We analyzed large nationwide databases, including the National Inpatient Sample and the Nationwide Readmissions Database. The prevalence of HD complicating deliveries ranges from approximately 20–40 cases per 10,000 deliveries. Increasing trends were observed in CHD, ARR, and HF. HF, particularly peripartum CM, is a leading cause of adverse maternal outcomes, including in-hospital mortality and SMM. VHD prevalence has declined, whereas ARR has become the most prevalent HD during pregnancy hospitalizations. Significant gaps exist due to inconsistent definitions and methodologies, limiting comparability and clinical utility. Proposed solutions include adopting standardized definitions, developing a core outcome set, improving data quality through structured documentation and standardized data models, and using validated algorithms and indices. Collaboration among multidisciplinary teams is essential to enhance research quality.
Conclusion:
The efforts aligning definitions of HD, outcomes, and indices with public health measures and initiatives present an opportunity to create a unifying framework that connects patient-level data to system-wide improvements. This integration helps ensure that advances in methodology translate into better care delivery, billing accuracy, research quality, and public health surveillance, and ultimately enhance outcomes for pregnant women with HD.
ToledoI, CzarnyH, DeFrancoE, et al.Delivery-related maternal morbidity and mortality among patients with cardiac disease. Obstet Gynecol, 2025; 145(1):e1–e10; doi: 10.1097/AOG.0000000000005780
BrillerJ, TrostSL, BusackerA, et al.Pregnancy-related mortality due to cardiovascular conditions: Maternal mortality review committees in 32 U.S. States, 2017 to 2019. JACC Adv, 2024; 3(12):101382; doi: 10.1016/j.jacadv.2024.101382
4.
LearyPJ, LearySES, StoutKK, et al.Maternal, perinatal, and postneonatal outcomes in women with chronic heart disease in Washington State. Obstet Gynecol, 2012; 120(6):1283–1290; doi: 10.1097/aog.0b013e3182733d56
5.
DucasRA, JavierDA, D’SouzaR, et al.Pregnancy outcomes in women with significant valve disease: A systematic review and meta-analysis. Heart, 2020; 106(7):512–519; doi: 10.1136/heartjnl-2019-315859
6.
HardeeI, WrightL, McCrackenC, et al.Maternal and neonatal outcomes of pregnancies in women with congenital heart disease: A Meta-Analysis: A meta-analysis. J Am Heart Assoc, 2021; 10(8):e017834; doi: 10.1161/JAHA.120.017834
7.
YoungBT, BaerRJ, ChambersCD, et al.What drives outcomes in infants of mothers with congenital heart disease? A mediation analysis. J Perinatol, 2024; 44(3):366–372; doi: 10.1038/s41372-023-01796-0
8.
LimaFV, YangJ, XuJ, et al.National trends and in-hospital outcomes in pregnant women with heart disease in the United States. Am J Cardiol, 2017; 119(10):1694–1700; doi: 10.1016/j.amjcard.2017.02.003
9.
WilliamsonCG, AltendahlM, MartinezG, et al.Cardiovascular disease in pregnancy: Clinical outcomes and cost-associated burdens from a national cohort at delivery. JACC Adv, 2024; 3(8):101071; doi: 10.1016/j.jacadv.2024.101071
10.
MalhaméI, NerenbergK, McLaughlinK, et al.Hypertensive disorders and cardiovascular severe maternal morbidity in the US, 2015–2019. JAMA Netw Open, 2024; 7(10):e2436478; doi: 10.1001/jamanetworkopen.2024.36478
11.
MajmundarM, DoshiR, PatelKN, et al.Prevalence, trends, and outcomes of cardiovascular diseases in pregnant patients in the USA: 2010–2019. Eur Heart J, 2023; 44(9):726–737; doi: 10.1093/eurheartj/ehac669
12.
HoyertDL. Maternal mortality rates in the United States. NCHS Health E-Stats. 2024, 2021; doi: 10.15620/cdc:124678
13.
BarrettML, HenscheMB, WelchJ, et al.Healthcare Cost and Utilization Project (HCUP) National Inpatient Sample: Change in Structure Due to ICD-10-CM/PCS Beginning With 2016 Data. 2022. U.S. Agency for Healthcare Research and Quality. Available from: www.hcupus.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp. [Last accessed: August25, 2025].
14.
Health Cost and Utilization Project. NRD description of data elements; Agency for Healthcare Research and Quality. 2024. Available from: www.hcup-us.ahrq.gov/db/nation/nrd/nrddde.jsp [Last accessed: April30, 2025].
Centers for Medicare and Medicaid Services (CMS), National Center for Health Statistics (NCHS). ICD-10-CM Official Guidelines for Coding and Reporting. 2022. FY2022 April1 update ICD-10-CM Guidelines (cms.gov) [September 8, 2023].
17.
MogosMF, PianoMR, McFarlinBL, et al.Heart failure in pregnant women: A concern across the pregnancy continuum. Circ Heart Fail, 2018; 11(1):e004005.
18.
KuklinaE, CallaghanW. Chronic heart disease and severe obstetric morbidity among hospitalizations for pregnancy in the USA: 1995-2006. BJOG, 2011; 118(3):345–352; doi: 10.1111/j.1471-0528.2010.02743.x
19.
HallC, ShishkinaA, ThurmanR, et al.Outcome reporting in cardio-obstetrics studies: A systematic review. Am Heart J, 2024; 278:223–234; doi: 10.1016/j.ahj.2024.09.008
20.
CallaghanWM, CreangaAA, KuklinaEV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol, 2012; 120(5):1029–1036; doi: 10.1097/aog.0b013e31826d60c5
Alliance for Innovation on Maternal Health (AIM). 2024 AIM SMM codes list (XLSX) v05-14-2024. Available from: https://saferbirth.org/aim-data/resources/ [Last accessed: August20, 2024].
SattiDI, ChoiE, PatelHP, et al.Cardiomyopathies in pregnancy: Trends and clinical outcomes in delivery hospitalizations in the United States (2005–2020). Curr Probl Cardiol, 2024; 49(12):102855; doi: 10.1016/j.cpcardiol.2024.102855
26.
AbabioY, KellySP, AngeliFS, et al.Prevalence and Clinical Burden of Idiopathic Dilated Cardiomyopathy in the United States. Am J Med Open, 2023; 10:100038; doi: 10.1016/j.ajmo.2023.100038
27.
BasitH, AlahmadiMH, RoutP, et al.Hypertrophic Cardiomyopathy. [Updated 2024 Jun 7]. In: StatPearls [Internet]. StatPearls Publishing: Treasure Island (FL); 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430788/
28.
DavisMB, AranyZ, McNamaraDM, et al.Peripartum cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol, 2020; 75(2):207–221; doi: 10.1016/j.jacc.2019.11.014
29.
IjazSH, JamalS, MinhasAMK, et al.Trends in characteristics and outcomes of peripartum cardiomyopathy hospitalizations in the United States between 2004 and 2018. Am J Cardiol, 2022; 168:142–150; doi: 10.1016/j.amjcard.2021.12.034
30.
PathakI, KuklinaEV, HollierLM, et al.Cardiomyopathy prevalence and pregnancy-related mortality: United States, 2010 to 2020. JACC Adv, 2025; 4(5):101692; doi: 10.1016/j.jacadv.2025.101692
31.
GrotegutCA, KuklinaEV, AnstromKJ, et al.Factors associated with the change in prevalence of cardiomyopathy at delivery in the period 2000-2009: A population-based prevalence study. BJOG, 2014; 121(11):1386–1394; doi: 10.1111/1471-0528.12726
32.
KolteD. Understanding the association between hypertensive disorders of pregnancy and peripartum cardiomyopathy. Eur J Heart Fail, 2017; 19(12):1721–1722; doi: 10.1002/ejhf.941
33.
EggletonEJ, McMurrughKJ, AikenCE. Perinatal outcomes in pregnancies complicated by maternal cardiomyopathy: A systematic review and meta-analysis. Am J Obstet Gynecol, 2023; 228(3):283–291; doi: 10.1016/j.ajog.2022.09.025
34.
ManR, Le VanceJ, AbdullahiH, et al.Maternal and fetal outcomes in subsequent pregnancies after peripartum cardiomyopathy: A systematic review and meta-analysis. Acta Obstet Gynecol Scand, 2025; 104(6):1009–1025; doi: 10.1111/aogs.15117
35.
WilkieGL, QureshiWT, O’DayKW, et al.Cardiac and obstetric outcomes associated with mitral valve prolapse. Am J Cardiol, 2022; 162:150–155; doi: 10.1016/j.amjcard.2021.09.014
MinhasAS, RahmanF, GavinN, et al.Cardiovascular and obstetric delivery complications in pregnant women with valvular heart disease. Am J Cardiol, 2021; 158:90–97; doi: 10.1016/j.amjcard.2021.07.038
39.
NgAP, VermaA, SanaihaY, et al.Maternal and fetal outcomes in pregnant patients with mechanical and bioprosthetic heart valves. J Am Heart Assoc, 2023; 12(10):e028653; doi: 10.1161/JAHA.122.028653
40.
ThakkarA, KwapongYA, PatelH, et al.Temporal trends of arrhythmias at delivery hospitalizations in the United States: Analysis from the National Inpatient Sample, 2009-2019. Front Cardiovasc Med, 2022; 9:1000298; doi: 10.3389/fcvm.2022.1000298
VaidyaVR, AroraS, PatelN, et al.Burden of arrhythmia in pregnancy. Circulation, 2017; 135(6):619–621; doi: 10.1161/CIRCULATIONAHA.116.026681
43.
VerheulLM, GroeneveldSA, KirkelsFP, et al.State-of-the-Art multimodality imaging in sudden cardiac arrest with focus on idiopathic ventricular fibrillation: A review. J Clin Med, 2022; 11(16):4680; doi: 10.3390/jcm11164680
44.
ThompsonJL, KuklinaEV, BatemanBT, et al.Medical and obstetric outcomes among pregnant women with congenital heart disease. Obstet Gynecol, 2015; 126(2):346–354; doi: 10.1097/AOG.0000000000000973
45.
LevineLD, FriedmanAM, KimYY, et al.Postpartum readmissions among adult congenital heart disease patients. Am J Obstet Gynecol MFM, 2025; 7(2):101580; doi: 10.1016/j.ajogmf.2024.101580
46.
LindleyK, Bairey MerzC, AsgarA, et al.Management of women with congenital or inherited cardiovascular disease from pre-conception through pregnancy and postpartum: JACC Focus Seminar 2/5. JACC, 2021; 77(14):1778–1798; doi: 10.1016/j.jacc.2021.02.026
47.
KuklinaEV, WhitemanMK, HillisSD, et al.An enhanced method for identifying obstetric deliveries: Implications for estimating maternal morbidity. Matern Child Health J, 2008; 12(4):469–477; doi: 10.1007/s10995-007-0256-6
48.
ClappMA, JamesKE, FriedmanAM. Identification of delivery encounters using International Classification of Diseases, Tenth Revision, diagnosis and procedure codes. Obstet Gynecol, 2020; 136(4):765–767; doi: 10.1097/AOG.0000000000004099
49.
AdmonLK, FordND, KoJY, et al.Trends and distribution of in-hospital mortality among pregnant and postpartum individuals by pregnancy period [published correction appears. JAMA Netw Open, 2022; 5(7):e2232512; doi: 10.1001/jamanetworkopen.2022.32512; in JAMA Netw Open. 2022;5(7):e2224614. Published 2022 Jul 1. doi:10.1001/jamanetworkopen.2022.24614
50.
PhiriK, Hernandez-DiazS, TsenLC, et al.Accuracy of ICD-9-CM coding to identify small for gestational age newborns. Pharmacoepidemiol Drug Saf, 2015; 24(4):381–388; doi: 10.1002/pds.3740
51.
WangX, WangY, ZhuY, et al.Validation of diagnosis codes for low birth weight and small-for-gestational age in the medicaid analytic extract database. Am J Epidemiol, 2025; 194(10):2887–2895; doi: 10.1093/aje/kwae472
52.
EbbersT, KoolRB, SmeeleLE, et al.The impact of structured and standardized documentation on documentation quality; A multicenter, retrospective study. J Med Syst, 2022; 46(7):46; doi: 10.1007/s10916-022-01837-9
53.
EbbersT, TakesRP, SmeeleLE, et al.The implementation of a multidisciplinary, electronic health record embedded care pathway to improve structured data recording and decrease electronic health record burden. Int J Med Inform, 2024; 184:105344; doi: 10.1016/j.ijmedinf.2024.105344
54.
KonradR, ZhangW, BjarndóttirM, et al.Key considerations when using health insurance claims data in advanced data analyses: An experience report. Health Syst (Basingstoke), 2019; 9(4):317–325; doi: 10.1080/20476965.2019.1581433
55.
MalhaméI, MehtaN, RakerCA, et al.Identifying cardiovascular severe maternal morbidity in epidemiologic studies. Paediatr Perinat Epidemiol, 2020; 34(4):452–459; doi: 10.1111/ppe.12571
56.
D’SouzaR, OROS-investigators. Outcome Reporting in Obstetric Studies (OROS) Project. Department of Obstetrics & Gynaecology, University of Toronto. 2019. Available from: https://obgyn.utoronto.ca/oros-project [Last accessed: April10, 2025].
57.
DuffyJ, CairnsAE, Richards-DoranD, et al.; International Collaboration to Harmonise Outcomes for Pre-eclampsia (iHOPE). A core outcome set for pre-eclampsia research: An international consensus development study. BJOG, 2020; 127(12):1516–1526; doi: 10.1111/1471-0528.16319
58.
BrodowskiL, KnothM, ZehnerL, et al.Assessing severity and need for delivery in early onset preeclampsia before 32 weeks of gestation: A Delphi Consensus Procedure. Geburtshilfe Frauenheilkd, 2024; 84(8):760–772; doi: 10.1055/a-2361-0563
59.
DeyD, HaqueMS, IslamMM, et al.The proper application of logistic regression model in complex survey data: A systematic review. BMC Med Res Methodol, 2025; 25(1):15; doi: 10.1186/s12874-024-02454-5
60.
SharabianiMTA, AylinP, BottleA. Systematic review of comorbidity indices for administrative data. Med Care, 2012; 50(12):1109–1118; doi: 10.1097/MLR.0b013e31825f64d0
61.
BatemanBT, MhyreJM, Hernandez-DiazS, et al.Development of a comorbidity index for use in obstetric patients. Obstet Gynecol, 2013; 122(5):957–965; doi: 10.1097/AOG.0b013e3182a603bb
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
